Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)

Summary

The Lung HIV goal is to facilitate the data and specimen collection efforts of eight individual HIV and pulmonary studies that operate under the direction of the NHLBI. The Lung HIV study will build on existing studies to facilitate the start-up of new projects to further the understanding of the relationship between pulmonary disease and HIV infection. There is only one clinical trial being performed in this network at Ohio State University and it will be reported here.

Conditions

• Pulmonary Complications
• HIV Infections

Interventions

OTHER

Smoking Cessation

A Motivational Interview session (\~40-50 minutes) will be delivered by a trained nurse coordinator. Treatment with varenicline (1 mg daily during week 1 (pre-quit week) followed by 1 mg twice daily for weeks 2-12)or nicotine replacement therapy (21 mg of a skin patch + nicotine gum 4 mg ad lib added for breakthrough craving up to 20 pieces/day.

Sponsors & Collaborators

• Johns Hopkins University

  collaborator OTHER

• Johns Hopkins Bloomberg School of Public Health

  collaborator OTHER

• New York University

  collaborator OTHER

• Ohio State University

  collaborator OTHER

• University of California, San Francisco

  collaborator OTHER

• University of Colorado, Denver

  collaborator OTHER

• University of Pittsburgh

  collaborator OTHER

• University of Washington

  collaborator OTHER

• National Heart, Lung, and Blood Institute (NHLBI)

  lead NIH

Principal Investigators

• Hannah Peavy, MD · NHLBI Project Officer

Study Design

Allocation

NA

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2007-09-30

Primary Completion

2012-06-30

Completion

2013-11-30

Countries

• United States

Study Locations